TPCW
PRAX icon

TD Private Client Wealth’s Praxis Precision Medicines PRAX Stock Holding History

TD Private Client Wealth’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670 Buy
+2
New +$633 ﹤0.01% 1530
2025
Q2 		– Sell
-11
Closed -$417 – 1493
2025
Q1 		$417 Buy
+11
New +$687 ﹤0.01% 1350

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

TD Private Client Wealth's PRAX Position: Q2 2026 in Review

TD Private Client Wealth opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 2 shares worth $670. The stake represents ﹤0.01% of the portfolio and ranks #1530 among its holdings. This is a return to the name: TD Private Client Wealth previously reported a position in PRAX as recently as Q1 2025.

TD Private Client Wealth first reported a position in PRAX in Q1 2025 and has held it in 2 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • TD Private Client Wealth held 2 shares of Praxis Precision Medicines worth $670 as of Q2 2026.
  • Praxis Precision Medicines was a new TD Private Client Wealth position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1530 holding.
  • TD Private Client Wealth first reported a position in Praxis Precision Medicines in Q1 2025 and has held it in 2 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.